peer-reviewedBackground: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly managed by General Practitioners (GPs). Objectives: To investigate the proportion of people with T2DM who are prescribed either antidepressant or benzodiazepine medications in general practice; to compare people with T2DM that have a prescription with those that do not in terms of patient characteristics, glycaemic control and healthcare utilization. Methods: Anonymized data was collected by GPs and senior medical students from electronic medical records of patients with T2DM in 34 Irish general practices affiliated with the University of Limerick Graduate Entry Medical School during the 2013/14 academic year. Data included demograp...
BACKGROUND: Poorly controlled type 2 diabetes mellitus (T2DM) can be seen as failure to meet recomme...
Background: Depression incidence is higher in diabetic patients when compared to the non-diabetic in...
Aim: To determine whether the prescribing of non-insulin anti-hyperglycaemic medications in Australi...
Background: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly manag...
<strong>Objective <\strong> With depression being present in approximately 20% of people with type ...
Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitu...
Background: Treatment guidelines do not provide specific recommendations for antidepressant prescrib...
Context: Depression is common in people with diabetes and is associated with poor glycemic control. ...
AIM: In adults with comorbid depression and type 2 diabetes (T2DM), to determine: Objective 1: Th...
BACKGROUND/AIMS The aim of this study was to identify the trends in antidepressant (AD) medication ...
OBJECTIVES: Dapagliflozin is an inhibitor of the human sodium-glucose co-transporter 2 (SGLT2) that ...
<p>Context: Depression is common in people with diabetes and is associated with poor glycemic contro...
Background: Data from primary care regarding the prevalence of symptoms of depression and anxiety, a...
Background: This study measures the use of drugs within the therapeutic areas of antithrombotic agen...
Background: Because comorbid depression can complicate medical conditions (eg, diabetes), physi-cian...
BACKGROUND: Poorly controlled type 2 diabetes mellitus (T2DM) can be seen as failure to meet recomme...
Background: Depression incidence is higher in diabetic patients when compared to the non-diabetic in...
Aim: To determine whether the prescribing of non-insulin anti-hyperglycaemic medications in Australi...
Background: Comorbid anxiety and depression and type two diabetes mellitus (T2DM) are commonly manag...
<strong>Objective <\strong> With depression being present in approximately 20% of people with type ...
Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitu...
Background: Treatment guidelines do not provide specific recommendations for antidepressant prescrib...
Context: Depression is common in people with diabetes and is associated with poor glycemic control. ...
AIM: In adults with comorbid depression and type 2 diabetes (T2DM), to determine: Objective 1: Th...
BACKGROUND/AIMS The aim of this study was to identify the trends in antidepressant (AD) medication ...
OBJECTIVES: Dapagliflozin is an inhibitor of the human sodium-glucose co-transporter 2 (SGLT2) that ...
<p>Context: Depression is common in people with diabetes and is associated with poor glycemic contro...
Background: Data from primary care regarding the prevalence of symptoms of depression and anxiety, a...
Background: This study measures the use of drugs within the therapeutic areas of antithrombotic agen...
Background: Because comorbid depression can complicate medical conditions (eg, diabetes), physi-cian...
BACKGROUND: Poorly controlled type 2 diabetes mellitus (T2DM) can be seen as failure to meet recomme...
Background: Depression incidence is higher in diabetic patients when compared to the non-diabetic in...
Aim: To determine whether the prescribing of non-insulin anti-hyperglycaemic medications in Australi...